Show summary Hide summary
Michael J Fox is counting on his closest ally in the fight to end Parkinson’s disease. The iconic actor revealed he believes Ryan Reynolds will carry on the mission after he’s gone, transforming a decades-long friendship into a powerful legacy that could reshape hope for millions.
🔥 Quick Facts
- Board Position: Reynolds joined the Michael J. Fox Foundation board in 2009, serving 17 consecutive years.
- Diagnosis Timeline: Fox received his Parkinson’s diagnosis at age 29 in 1991, now 64.
- Foundation Impact: The organization has raised over $2 billion for research toward a cure.
- Reynolds’ Vision: Fox sees Reynolds as successor to champion the cause with determination and compassion.
A Friendship Built on Purpose and Passion
Ryan Reynolds and Michael J Fox share far more than Hollywood fame. Their bond, which began 17 years ago, reflects a deep mutual respect forged through shared values. Reynolds wrote in a Time Magazine tribute that he’s watched Fox raise the bar for purpose and passion. The actor credits Fox with helping his own father, James Reynolds, feel less alone during his nearly 20-year battle with Parkinson’s.
Reynolds, now 49 years old, has repeatedly emphasized that his involvement with the foundation is deeply personal. Fox’s resilience and public advocacy transformed how Reynolds views the disease and his own family’s experience with it.
The Bride delivers bold Frankenstein reimagining with Jessie Buckley, drops March 6
Olivia Wilde stuns in plunging catsuit at Paris Fashion Week
From Personal Loss to Powerful Legacy
When James Reynolds passed away in 2015 following complications from neurological movement disorders, Ryan faced the profound pain of losing a parent to disease. Yet rather than withdraw, Reynolds channeled his grief into action. According to sources close to both men, Reynolds’ commitment to the Michael J. Fox Foundation became his way of honoring his father’s memory while supporting countless families facing the same struggle.
Fox recognized this shift in Reynolds’ involvement. The actor sees it as more than charity—it’s a succession plan ensuring the fight continues with star power and authentic passion for decades to come.
The Foundation’s Remarkable Progress and Future
| Milestone | Details |
| Foundation Founded | 2000 by Michael J. Fox |
| Total Funding Raised | Over $2 billion |
| Predicted Cure Timeline | Within 40 years |
| Reynolds Board Service | Since 2009 (17 years) |
The Michael J. Fox Foundation has achieved extraordinary breakthroughs in research. Just last year, the foundation announced major advances in identifying Parkinson’s biomarkers, moving the entire field closer to early diagnosis and prevention. Fox has publicly stated his confidence that a cure is possible within 40 years, a bold timeline grounded in genuine scientific progress. Reynolds’ continued leadership ensures these victories won’t be forgotten even as timelines shift.
“With friends like Ryan, it’s easier to accomplish anything. He truly believes in this mission.”
— Michael J. Fox, regarding his longtime ally
More Than Charity: A Ruthlessly Committed Advocate
Those close to Reynolds describe him as someone who operates on principle rather than public relations. The Deadpool actor is known for his business acumen and competitive intensity, yet when it comes to Parkinson’s research, he operates with unmistakable sincerity. Sources emphasize that Reynolds doesn’t perform his activism—he lives it. His father’s experience shaped him in ways that transcend typical celebrity charity work.
Reynolds has openly discussed his father’s reluctance to publicly acknowledge his illness, a silent struggle that mirrors many families’ experiences. By serving on the foundation board, Reynolds transforms private pain into public momentum, helping destigmatize a disease that affects 6 million people worldwide.
What Does This Succession Plan Mean for Future Cures?
Fox’s confidence in Reynolds suggests stability in the foundation’s leadership for years to come. The Back to the Future legend has built something far larger than himself: an institution dedicated to relentless pursuit of cures. With Reynolds at the helm of advocacy efforts, the foundation gains a successor with genuine credibility, unlimited resources, and a personal stake in victory against this disease. This partnership signals to researchers and donors alike that the mission remains unshakable, drawing the brightest scientific minds toward solutions that could transform millions of lives globally.
